AUBURN NATIONAL BANCORPORATION, INC AUBN
Nasdaq · stock · State Commercial Banks · website · IPO 1995-07-20
AUBURN NATIONAL BANCORPORATION, INC financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $619,000 | $614,000 | $603,000 | $598,000 | $566,000 | $585,000 | $717,000 | $749,000 | $746,000 | — |
| Interest expense | $11.1M | $11.6M | $8.0M | $2.4M | $2.5M | $3.9M | $4.2M | $3.7M | $3.6M | $4.1M |
| Income tax | $2.0M | $2.0M | -$777,000 | $2.5M | $1.4M | $1.6M | $2.4M | $2.2M | $3.6M | $3.1M |
| Operating cash flow | $12.3M | $10.8M | $11.9M | $11.0M | $12.3M | $9.7M | $10.8M | $12.1M | $9.4M | $10.5M |
| Free cash flow | $10.9M | $8.7M | $11.5M | $3.9M | -$7.9M | — | — | — | — | — |
| Total assets | $1.0B | $977.3M | $975.3M | $1.0B | $1.1B | $956.6M | $827.9M | $818.1M | $853.4M | $831.9M |
| Total liabilities | $926.7M | $899.0M | $898.7M | $955.8M | $1.0B | $848.9M | $729.6M | $729.0M | $766.5M | $749.8M |
| Shareholders' equity | $92.1M | $78.3M | $76.5M | $68.0M | $103.7M | $107.7M | $98.3M | $89.1M | $86.9M | $82.2M |
| EPS (diluted) | $2.08 | $1.83 | — | — | — | — | — | — | — | — |
Growth · year-over-year · Revenue CAGR -2.3%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +0.8% | +1.8% | +0.8% | +5.7% | -3.2% | -18.4% | -4.3% | +0.4% | — | — |
| EPS growth | +13.7% | — | — | — | — | — | — | — | — | — |
| Free cash flow growth | +24.6% | -24.1% | +192.1% | — | — | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.